Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an update.
Recordati S.p.A. announced the approval of its 2024 financial statements and a dividend increase to €1.27 per share, reflecting a 5.8% rise from the previous year. Additionally, a new Board of Directors was appointed for the 2025-2027 period, with Andrea Recordati and Robert Koremans confirmed as Chairman and CEO, respectively. The company also renewed its authorization to purchase and dispose of treasury shares and approved a new share purchase program to support stock option and performance share plans.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is a pharmaceutical company based in Milan, Italy, primarily engaged in the research, development, manufacturing, and marketing of pharmaceuticals. The company focuses on specialty and primary care products and operates in a global market.
YTD Price Performance: -2.73%
Average Trading Volume: 25,406
Technical Sentiment Signal: Hold
Current Market Cap: €10.12B
For an in-depth examination of REC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue